MAMMONE, GIULIA
 Distribuzione geografica
Continente #
EU - Europa 144
NA - Nord America 130
AS - Asia 43
AF - Africa 2
Totale 319
Nazione #
US - Stati Uniti d'America 127
IT - Italia 83
SE - Svezia 27
SG - Singapore 19
CN - Cina 12
DE - Germania 11
IN - India 5
BG - Bulgaria 4
CA - Canada 3
ES - Italia 3
ID - Indonesia 3
CZ - Repubblica Ceca 2
FI - Finlandia 2
FR - Francia 2
IE - Irlanda 2
IR - Iran 2
LT - Lituania 2
NL - Olanda 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
GB - Regno Unito 1
IL - Israele 1
RU - Federazione Russa 1
SC - Seychelles 1
TG - Togo 1
Totale 319
Città #
Chandler 22
Rome 19
Fairfield 11
Singapore 11
Ashburn 10
Houston 8
Cambridge 6
New York 6
San Paolo di Civitate 6
Santa Clara 6
Bremen 5
Milan 5
Wilmington 5
Seattle 4
Sofia 4
Woodbridge 4
Beijing 3
Jakarta 3
Lawrence 3
Princeton 3
Boston 2
Dublin 2
Helsinki 2
Madrid 2
Petilia Policastro 2
Romainville 2
Rosora 2
Toronto 2
Turin 2
Amsterdam 1
Andover 1
Ann Arbor 1
Arrecife 1
Azor 1
Carlentini 1
Chieti 1
Dallas 1
Dubai 1
Edinburgh 1
Falkenstein 1
Francavilla Fontana 1
Fremont 1
Guangzhou 1
Kish 1
Livorno 1
Lomé 1
Los Angeles 1
Millbury 1
Mirano 1
Montichiari 1
Montréal 1
Moscow 1
Pescara 1
Reggio Calabria 1
Sacramento 1
San Diego 1
Shanghai 1
Xuzhou 1
Zanjan 1
Totale 192
Nome #
Weekly chemotherapy as first line treatment in frail head and neck cancer patients in the immunotherapy era 92
The role of opioids in cancer response to immunotherapy 75
The impact of locoregional treatment on response to Nivolumab in advanced platinum refractory head and neck cancer: the NEED TRIAL 74
3MO Oncogenic non-G12C {KRAS} mutations in {KRAS} G12C mutated lung adenocarcinomas in {TRACERx} and {GENIE}: A reservoir for intrinsic resistance to {KRAS} G12C inhibitors 49
Comparative effects of Folfirinox and Gemcitabine/nab-paclitaxel as first and second line chemotherapy for metastatic pancreatic cancer: single choice or sequence 38
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations. Differential Effectiveness by Risk Group? 15
Totale 343
Categoria #
all - tutte 1.595
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.595


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202012 0 0 0 0 0 0 0 0 0 8 2 2
2020/202120 0 2 0 1 1 1 0 0 3 5 1 6
2021/202280 23 9 1 3 6 4 1 3 1 5 19 5
2022/2023119 28 21 9 12 16 9 0 7 7 3 7 0
2023/202454 2 4 4 8 4 12 8 5 1 3 1 2
2024/202558 7 5 13 12 9 12 0 0 0 0 0 0
Totale 343